Helicobacter pylori: Bacterial Factors and the Role of Cytokines in the Immune Response

被引:29
|
作者
Beatriz Romero-Adrian, Tania [1 ]
Leal-Montiel, Jorymar [1 ]
Monsalve-Castillo, Francisca [2 ]
Mengual-Moreno, Edgardo [1 ]
Garcia McGregor, Ernesto [3 ]
Perini, Lenis [3 ]
Antunez, Ana [3 ]
机构
[1] Univ Zulia, Inst Biol Res, Fac Med, Panamericano Sector, Maracaibo 4011, Venezuela
[2] Univ Zulia, Bioanal Sch, Fac Med, Maracaibo 4011, Venezuela
[3] Cent Hosp Dr Urquinaona, Rheumatol Unit, Maracaibo, Zulia, Venezuela
关键词
NECROSIS-FACTOR-ALPHA; GASTRIC EPITHELIAL-CELLS; OXIDATIVE DNA-DAMAGE; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; VACUOLATING CYTOTOXIN; SERUM-LEVELS; INTERLEUKIN-1; POLYMORPHISMS; TYROSINE PHOSPHORYLATION; GENE POLYMORPHISMS;
D O I
10.1007/s00284-009-9518-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Helicobacter pylori is a gram-negative micro-aerophilic bacterium that is widely distributed geographically and causes chronic gastritis, peptic ulcers, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. Bacterial virulence factors play an important role, since the virulent strains are more aggressive and increase the risk of developing severe clinical manifestations; in addition, other determinant factors are the nutritional state and the immune response of the host. Studies on humans, non-human primates, and rodents have reported that regulating proteins of the Th1 phenotype predominate in the immune response to the bacterial infection. The cytokines produced by this phenotype, are not very effective in eradicating the microorganism and furthermore, contribute to gastro-duodenal pathogenesis. Gastric inflammation in patients infected with H. pylori has been characterized by increased production of IL-1, IL-6, IL-12, IL-18, TNF-alpha, and IFN-gamma. Many prophylactic and therapeutic strategies have been researched using experimental animals. The utilization and effectiveness of vaccination on humans requires more study.
引用
收藏
页码:143 / 155
页数:13
相关论文
共 50 条
  • [1] Helicobacter pylori: Bacterial Factors and the Role of Cytokines in the Immune Response
    Tania Beatriz Romero-Adrián
    Jorymar Leal-Montiel
    Francisca Monsalve-Castillo
    Edgardo Mengual-Moreno
    Ernesto García McGregor
    Lenis Perini
    Ana Antúnez
    Current Microbiology, 2010, 60 : 143 - 155
  • [2] Bacterial factors and immune pathogenesis in Helicobacter pylori infection
    Shimoyama, T
    Crabtree, JE
    GUT, 1998, 43 : S2 - S5
  • [3] The immune response to Helicobacter pylori
    Ihan, A. (alojz.ihan@mf.uni-lj.si), 1600, University of Zagreb (52):
  • [4] The Immune Response to Helicobacter pylori
    Ihan, Alojz
    Gubina, Marija
    FOOD TECHNOLOGY AND BIOTECHNOLOGY, 2014, 52 (02) : 204 - 209
  • [5] Bacterial and immune factors of the intervening host in the evolution of Helicobacter pylori gastritis
    Lamarque, D
    ANNALES DE PATHOLOGIE, 2002, 22 : S25 - S27
  • [6] Dendritic cell maturation and release of cytokines, chemokines, and growth factors in response to Helicobacter pylori:: Role of the urease
    Kovach, Z.
    Puz, S.
    Hirschl, A. M.
    Rotter, M.
    Makristathis, A.
    HELICOBACTER, 2006, 11 (04) : 329 - 329
  • [7] Molecular Pathogenesis of Helicobacter pylori Infection: The Role of Bacterial Virulence Factors
    Molnar, Bela
    Galamb, Orsolya
    Sipos, Ferenc
    Leiszter, Katalin
    Tulassay, Zsolt
    DIGESTIVE DISEASES, 2010, 28 (4-5) : 604 - 608
  • [8] Local immune response and virulence factors of Helicobacter pylori infection in Chile
    Araya, JC
    Roa, JC
    Cuba, M
    Anabalón, L
    Sierralta, A
    Ríos, E
    Roa, I
    HELICOBACTER, 2005, 10 (05) : 479 - 479
  • [9] Analysis of the role of galectin-3 in the immune response to Helicobacter pylori
    Flood, W. G.
    High, D. N.
    IMMUNOLOGY, 2011, 135 : 176 - 176
  • [10] Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis
    de Brito, Breno Bittencourt
    Franca da Silva, Filipe Antonio
    de Melo, Fabricio Freire
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (05): : 83 - 89